Form SCHEDULE 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P. Feb 13, 2026 04:06PM
Form SCHEDULE 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P. Aug 11, 2025 06:57PM
Form SCHEDULE 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P. Mar 20, 2025 07:55PM
Form SC 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P. Nov 8, 2024 06:58PM
Form SC 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P. May 21, 2024 06:35PM


Apr 25, 2022 05:05PM Form SC 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
Apr 7, 2022 08:06AM Trevi Therapeutics (TRVI) Announces $55 Million Private Placement of Common Stock, Warrants
Apr 7, 2022 08:00AM Trevi Therapeutics Announces $55 Million Private Placement Priced At-the-Market
Nov 2, 2021 09:10AM Form SC 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
Oct 19, 2021 09:09PM Form 4 Trevi Therapeutics, Inc. For: Oct 18 Filed by: New Enterprise Associates 16, L.P.
Apr 16, 2020 04:26PM Form SC 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
May 20, 2019 01:53PM Form SC 13D Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
May 7, 2019 01:29PM Trevi Therapeutics (TRVL) Prices 5.5M Share IPO at $10/Sh
May 7, 2019 01:22PM Trevi Therapeutics Announces Pricing of Initial Public Offering